Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/1996
03/21/1996WO1996008495A1 Fused indole and quinoxaline derivatives, their preparation and use
03/21/1996WO1996008494A1 Indole-2,3-dione-3-oxime derivatives, their preparation and use
03/21/1996WO1996008493A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008492A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008489A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
03/21/1996WO1996008484A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
03/21/1996WO1996008471A1 4-(4-methanesulfonamidophenyl)butylamine derivatives with antiarrhythmic activity
03/21/1996WO1996008463A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
03/21/1996WO1996008240A1 Use of aromatic halides for treating mammalian cell proliferation
03/21/1996WO1996008228A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
03/21/1996CA2200056A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2200055A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2199944A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
03/21/1996CA2199719A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996CA2199484A1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
03/21/1996CA2196064A1 4-(4-methanesulfonamidophenyl)butylamine derivatives with antiarrhythmic activity
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0702013A2 Imidazopyridines
03/20/1996EP0702012A1 Substituted isoxazole sulfonamides and their use as endothelin antagonists
03/20/1996EP0702009A1 Method for the preparation of 3-hydroxy-5-(2-(dimethylamino)-ethy1)-2,3-dihydro-4-(methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds
03/20/1996EP0702004A2 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amid derivatives
03/20/1996EP0702001A1 Fluoro-alkyl/alkenyl-substituted benzoylguanidinens and their use as medicament or diagnostic agent
03/20/1996EP0701991A1 Process for the preparation of lignin analogues and starting materials therefor
03/20/1996EP0701988A1 Substituted cyclopentane-di- and triones, their preparation and their use as chloride channel blockers
03/20/1996EP0701819A2 Novel compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701816A2 Percutaneous absorption preparation containing isosolide dinitrate
03/20/1996EP0701609A1 Inhibition of proliferation of vascular smooth muscle cell
03/20/1996EP0701606A1 Method of enhancing thrombolysis
03/20/1996EP0701554A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
03/20/1996EP0701450A1 Recombinant viruses and their use in gene therapy
03/20/1996EP0701442A1 New use of ambasilide
03/20/1996EP0556332B1 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
03/20/1996CN1119014A Benzopyranes as potassium channel openers
03/20/1996CN1119013A Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
03/20/1996CN1118990A Medicament for treating or preventing cerebrovascular diseases
03/20/1996CN1118783A A process for preparing novel pyrido (3,2-B)(1,5) benzothiazepines
03/20/1996CN1118688A Method for slowing progression of coronary artery atherosclerosis employing pravastation
03/20/1996CN1031342C Process for preparing 1,5-benzothiazepine derivatives
03/20/1996CN1031339C Process for preparation of heterocyclically substituted phenylacetic acid derivatives
03/19/1996US5500442 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
03/19/1996US5500434 Mixture of trandolapril and felodipine
03/19/1996US5500429 Cardiovascular
03/19/1996US5500428 Furyl-substituted purines and adenosine antagonists
03/19/1996US5500425 Chroman derivatives and a method of treating 5-HT mediated disorders
03/19/1996US5500420 Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
03/19/1996CA2109800C N-hydroxyurea derivatives which inhibit lipoxygenase
03/17/1996CA2158223A1 Method for the preparation of 3-hydroxy-5-¬2-(dimethylamino)- ethyl|-2,3-dihydro-4-(methoxy -phenyl)-1,5-benzothiazepin-4 5h)-one and use of the product for making pharmaceutically active compounds
03/17/1996CA2158222A1 Use of substituted cyclopentane- di- and triones
03/16/1996CA2158227A1 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amide derivatives
03/16/1996CA2158225A1 Imidazopyridines
03/15/1996CA2157754A1 Percutaneous absorption preparation
03/14/1996WO1996007658A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
03/14/1996WO1996007657A1 Pyrimido[5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them
03/14/1996WO1996007653A1 Endothelin receptor antagonists
03/14/1996WO1996007641A1 Heterocyclic derivative and medicine
03/14/1996WO1996007424A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/14/1996WO1996007415A1 Myocardial protection using benzothiazepinones
03/14/1996WO1996007400A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
03/14/1996WO1995034651A3 Corticotropin-releasing factor2 receptors
03/14/1996CA2199518A1 Heterocyclic derivative and medicine
03/14/1996CA2198862A1 Myocardial protection using benzothiazepinones
03/14/1996CA2198018A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response
03/13/1996EP0700999A2 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
03/13/1996EP0700905A1 Tricyclic pyrazole derivatives
03/13/1996EP0700904A1 Heterocyclic-N-oxide substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic, medicaments containing them as well as intermediates for their preparation
03/13/1996EP0700899A1 Substituted benzoylguanidines, a process for their preparation, their use as drug or diagnostic agents as well as medicaments containing them
03/13/1996EP0700438A1 Opioid receptors: compositions and methods
03/13/1996EP0700398A1 Psoralen derivatives, their preparation and use as medicaments
03/13/1996EP0700396A1 Piperidine derivatives, their preparation and use
03/13/1996EP0700389A1 Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
03/13/1996EP0700385A1 Novel compounds
03/13/1996EP0700383A1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
03/13/1996EP0700378A1 Compounds which release nitric oxide
03/13/1996EP0700304A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
03/13/1996EP0700301A1 Peptides and compounds that bind to elam-1
03/13/1996EP0700298A1 Therapeutic use of hemoglobin in the treatment of blood vessel blockage
03/13/1996EP0618899B1 Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
03/13/1996EP0544880B1 Method of preparing diacetyl rhein
03/13/1996EP0476113B1 Medicament for treating hyperlipidaemia and/or atherosclerosis
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996CN1118347A Benzotoudened 5-ringneterocycl, preparation and phamaceutical and diagnostic use of same
03/13/1996CN1031267C Compounds for anti-dementia medicine and its usage
03/13/1996CA2157998A1 Pharmaceutical compounds
03/12/1996US5498775 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation
03/12/1996US5498722 Hypotensives
03/12/1996US5498628 Naphthamide derivatives
03/12/1996US5498626 Acylaminoindole derivatives as 5-ht1 agonists
03/12/1996US5498623 4(5) substituted imidazoles and their preparation and use
03/12/1996US5498617 Bone disorders
03/12/1996US5498607 Anticholesterol agents
03/12/1996US5498418 Nitroglycerine plaster and process for its production
03/07/1996WO1996006943A1 Cell cycle regulated repressor and dna element
03/07/1996WO1996006940A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006939A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996WO1996006867A1 Method for controlling o-desulfation of heparin and compositions produced thereby
03/07/1996WO1996006854A1 Spirostanyl glycosidal crystals
03/07/1996WO1996006845A1 Substituted 9-alkyladenines
03/07/1996WO1996006842A1 Salts of an anti-migraine indole derivative
03/07/1996WO1996006841A1 Quinazoline derivative
1 ... 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 ... 1595